Ramziya M. Potekhina
Ramziya M. Potekhina has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniya Yu. Tarasova
Federal Center for Toxicological, Radiation and Biological Safety
6 shared publications - Sultan Yusupov
Federal Center for Toxicological, Radiation and Biological Safety
4 shared publications - D. A. Khuzin
Federal Center for Toxicological, Radiation and Biological Safety
3 shared publications - Polina V. Bykova
Federal Center for Toxicological, Radiation and Biological Safety
3 shared publications Radiation And Biological Safety Federal Center For Toxicological
3 shared publications- Farit Khabullovich Kalimullin
Federal Center for Toxicological, Radiation and Biological Safety
2 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 2,p. 46-52
Control of the safety of intranasal vaccine against respiratory syncytial infection of cattle
Due to the widespread prevalence of respiratory viral diseases, particularly respiratory syncytial infection (RSI), among young cattle, the development of vaccines for immunizing young calves is extremely important. One of the most promising areas is the development of intranasal vaccines, as they, along with general immunobiological protection, promote the development of local immunity in the mucous membranes. This method, in turn, allows for immunization without the risk of maternal blockade. At the same time, the safety of such vaccines should be given special attention, as the first days of life are the most critical period for any external influences. The aim of this study was to evaluate the safety of a candidate intranasal RSI vaccine, being developed at the Federal Center for Toxicological, Radiation and Biological Safety, using a laboratory animal model (rabbits). Safety testing was conducted in accordance with GOST 31926-2013 on Chinchilla rabbits (three animals per group). The lyophilized monovalent vaccine was presuspended in sterile saline. Intranasal, intraperitoneal, intramuscular, and subcutaneous administration routes were used for safety testing. Animals were observed for 14 days. The volume of vaccine administered was 1,0 cm3 intranasally, 10,0 cm3 intramuscularly, 10,0 cm3 subcutaneously, and 10,0 cm3 intraperitoneally per animal. The vaccine was considered safe if no deterioration in the general condition, visible tissue changes at the injection site, illness, or death of the animals was observed during this period. In addition, after 14 days, a postmortem autopsy of the rabbits was performed to determine the absence of a systemic negative effect of the vaccine on tissues and internal organs. Autopsy was performed using the Virchow method, with measurement of the weight of internal organs and opening of the nasal cavity to examine the labyrinth mucosa. The monovalent vaccine against RSI did not cause clinical signs of the disease or mortality in rabbits. Visual inspection and comparison of organ weights revealed no differences between the experimental and control groups. These results demonstrate the safety of the vaccine being developed.
- 19 August 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 2,p. 46-52
Open AccessControl of the safety of intranasal vaccine against respiratory syncytial infection of cattle
Due to the widespread prevalence of respiratory viral diseases, particularly respiratory syncytial infection (RSI), among young cattle, the development of vaccines for immunizing young calves is extremely important. One of the most promising areas is the development of intranasal vaccines, as they, along with general immunobiological protection, promote the development of local immunity in the mucous membranes. This method, in turn, allows for immunization without the risk of maternal blockade. At the same time, the safety of such vaccines should be given special attention, as the first days of life are the most critical period for any external influences. The aim of this study was to evaluate the safety of a candidate intranasal RSI vaccine, being developed at the Federal Center for Toxicological, Radiation and Biological Safety, using a laboratory animal model (rabbits). Safety testing was conducted in accordance with GOST 31926-2013 on Chinchilla rabbits (three animals per group). The lyophilized monovalent vaccine was presuspended in sterile saline. Intranasal, intraperitoneal, intramuscular, and subcutaneous administration routes were used for safety testing. Animals were observed for 14 days. The volume of vaccine administered was 1,0 cm3 intranasally, 10,0 cm3 intramuscularly, 10,0 cm3 subcutaneously, and 10,0 cm3 intraperitoneally per animal. The vaccine was considered safe if no deterioration in the general condition, visible tissue changes at the injection site, illness, or death of the animals was observed during this period. In addition, after 14 days, a postmortem autopsy of the rabbits was performed to determine the absence of a systemic negative effect of the vaccine on tissues and internal organs. Autopsy was performed using the Virchow method, with measurement of the weight of internal organs and opening of the nasal cavity to examine the labyrinth mucosa. The monovalent vaccine against RSI did not cause clinical signs of the disease or mortality in rabbits. Visual inspection and comparison of organ weights revealed no differences between the experimental and control groups. These results demonstrate the safety of the vaccine being developed.
- Open Access
- 7 January 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 511-519
Fusogel is an effective remedy for the treatment of cows with hoof diseases
In recent decades, hoof diseases have continued to cause significant damage to dairy cattle breeding. The most important condition for increasing the productivity and longevity of cows in dairy cattle breeding is effective prevention of hoof diseases and their timely treatment at the very beginning of the disease. A new drug, Fuzogel, has been developed at the Federal Center for Traumatology and Radiology of the Russian Academy of Sciences. The aim of the work was to evaluate the effectiveness of the new import-substituting drug, Fuzogel, in the form of a gel based on the active substances of copper and zinc metal complex compounds, in hoof diseases in cows. The gel form creates a mechanical barrier that prevents the development of infection by reducing the adhesion of vegetative and spore forms of bacteria and fungi to the tissues of the fingers and hooves. Tests of the effectiveness of this product in infectious and non -infectious hoof diseases in cows conducted in two agricultural enterprises indicate its high antimicrobial and anti-inflammatory activity in the initial and moderate severity of hoof lesions, rapid relief of the inflammatory response in such clinical manifestations of diseases as: digital dermatitis, ulcer of the pulp, coronary band, interdigital space vault, pododermatitis. "Fusogel", which does not contain antibiotics, can be used without restrictions on dairy cattle, which allows obtaining high-quality products (milk, meat, offal). After the use of "Fusogel" in cows with mild and moderate severity of the disease, previously detected vegetative forms of bacteria and microscopic fungi were completely absent, which positively affected the regenerative processes and restoration of hoof functions in cows. The high effectiveness of the drug allows its wide implementation in the system of measures to combat hoof diseases in cattle.
- 7 January 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 511-519
Open AccessFusogel is an effective remedy for the treatment of cows with hoof diseases
In recent decades, hoof diseases have continued to cause significant damage to dairy cattle breeding. The most important condition for increasing the productivity and longevity of cows in dairy cattle breeding is effective prevention of hoof diseases and their timely treatment at the very beginning of the disease. A new drug, Fuzogel, has been developed at the Federal Center for Traumatology and Radiology of the Russian Academy of Sciences. The aim of the work was to evaluate the effectiveness of the new import-substituting drug, Fuzogel, in the form of a gel based on the active substances of copper and zinc metal complex compounds, in hoof diseases in cows. The gel form creates a mechanical barrier that prevents the development of infection by reducing the adhesion of vegetative and spore forms of bacteria and fungi to the tissues of the fingers and hooves. Tests of the effectiveness of this product in infectious and non -infectious hoof diseases in cows conducted in two agricultural enterprises indicate its high antimicrobial and anti-inflammatory activity in the initial and moderate severity of hoof lesions, rapid relief of the inflammatory response in such clinical manifestations of diseases as: digital dermatitis, ulcer of the pulp, coronary band, interdigital space vault, pododermatitis. "Fusogel", which does not contain antibiotics, can be used without restrictions on dairy cattle, which allows obtaining high-quality products (milk, meat, offal). After the use of "Fusogel" in cows with mild and moderate severity of the disease, previously detected vegetative forms of bacteria and microscopic fungi were completely absent, which positively affected the regenerative processes and restoration of hoof functions in cows. The high effectiveness of the drug allows its wide implementation in the system of measures to combat hoof diseases in cattle.
- Open Access
- 3 June 2025
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 1,p. 382-392
Evaluation of the effectiveness of hoof baths in diseases of fingers and hooves in cows
The aim of the work was to determine the therapeutic and preventive and economic efficiency of using the "SV" product for dry hoof baths developed by the staff of the Federal State Budgetary Institution “FCTRBVNIVI” in the conditions of an agricultural enterprise unfavorable for diseases of fingers and hooves. With the course use of such baths for 20 days, the number of lame cows in the experimental group decreased by 69.57%, in the comparison group, where baths were carried out using a 10% solution of copper sulfate - by 34.78%, while in the control (intact) group the number of lame cows increased by 45.83%. The damage from diseases of the fingers and hooves was also calculated based on such indicators as: lost milk, decreased live weight and premature culling of animals, decreased offspring yield, increased service period, which significantly hinder the receipt of greater profit and the effectiveness of the production activities of the agricultural enterprise. The effectiveness of the measures taken against these diseases was determined during a comparative test of traditional "wet" and baths with the product developed by us. At the same time, the economic damage from diseases of the fingers and hooves, and the costs of veterinary measures using the "SV" product were minimal, and the economic effect was maximum. The economic efficiency of using "SV" was 2.2 rubles per ruble of costs. Savings in material costs when using the "SV" product in the experimental group compared to using a 10% solution of copper sulfate amounted to 856,000 rub. Thus, the developed product made it possible to improve the health of the experimental livestock in a short time with minimal costs. The results of the research, allowed the management of the agricultural enterprise to see the problem in more detail and in the future to make timely decisions on preventing, eliminating and (or) minimizing damage from diseases of the fingers and hooves of cattle.
- 3 June 2025
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 1,p. 382-392
Open AccessEvaluation of the effectiveness of hoof baths in diseases of fingers and hooves in cows
The aim of the work was to determine the therapeutic and preventive and economic efficiency of using the "SV" product for dry hoof baths developed by the staff of the Federal State Budgetary Institution “FCTRBVNIVI” in the conditions of an agricultural enterprise unfavorable for diseases of fingers and hooves. With the course use of such baths for 20 days, the number of lame cows in the experimental group decreased by 69.57%, in the comparison group, where baths were carried out using a 10% solution of copper sulfate - by 34.78%, while in the control (intact) group the number of lame cows increased by 45.83%. The damage from diseases of the fingers and hooves was also calculated based on such indicators as: lost milk, decreased live weight and premature culling of animals, decreased offspring yield, increased service period, which significantly hinder the receipt of greater profit and the effectiveness of the production activities of the agricultural enterprise. The effectiveness of the measures taken against these diseases was determined during a comparative test of traditional "wet" and baths with the product developed by us. At the same time, the economic damage from diseases of the fingers and hooves, and the costs of veterinary measures using the "SV" product were minimal, and the economic effect was maximum. The economic efficiency of using "SV" was 2.2 rubles per ruble of costs. Savings in material costs when using the "SV" product in the experimental group compared to using a 10% solution of copper sulfate amounted to 856,000 rub. Thus, the developed product made it possible to improve the health of the experimental livestock in a short time with minimal costs. The results of the research, allowed the management of the agricultural enterprise to see the problem in more detail and in the future to make timely decisions on preventing, eliminating and (or) minimizing damage from diseases of the fingers and hooves of cattle.
- 1 January 2024
- Published by FSBEI HE Mari State University in Vestnik of the Mari State University. Chapter “Agriculture. Economics”
- Vol. 10 (3)
Study of acute toxicity of the drug “SV” on laboratory animals
- 1 January 2024
- Published by FSBEI HE Mari State University in Vestnik of the Mari State University. Chapter “Agriculture. Economics”
- Vol. 10 (3)
Study of acute toxicity of the drug “SV” on laboratory animals
- 5 February 2023
- Published by Springer Nature
- p. 1777-1783
Study of Individual Field Isolates of the Genus Fusarium for the Ability to Synthesize Complex Proteins
- 5 February 2023
- Published by Springer Nature
- p. 1777-1783
Study of Individual Field Isolates of the Genus Fusarium for the Ability to Synthesize Complex Proteins
- 5 February 2023
- Published by Springer Nature
- p. 1784-1789
Analysis of Preserved Feed from Individual Farms of the Republic of Tatarstan
- 5 February 2023
- Published by Springer Nature
- p. 1784-1789
Analysis of Preserved Feed from Individual Farms of the Republic of Tatarstan
- Open Access
- 1 January 2023
- Published by Federal Center for Toxicological, Radiation and Biological Safety in The Veterinarian
- No. 2,p. 28-32
Evaluation of the effectiveness of the experimental composition as a therapeutic agent for diarrhea of young cattle
У телят молочного периода выращивания часто встречаются расстройства работы органов пищеварения, сопровождающиеся нарушением состава микрофлоры пищеварительного тракта со сдвигом соотношения в сторону условно-патогенных видов, что приводит к диарее, снижает продуктивность животных. В связи с этим не теряет актуальности вопрос разработки новых средств борьбы с расстройствами пищеварения продуктивного скота. Исследования проведены в трех хозяйствах Республики Мордовия, в экспериментах оценивали эффективность нового препарата (композиции, полученной на основе селимакцида и мицелиального гриба Fusarium sambucinum штамма ВКПМ F-139) как лечебного средства при диарее молодняка крупного рогатого скота. Из опытных животных - телят молочного периода выращивания - в каждом из трех опытов составляли 3 группы по 10 голов: 1 группа - здоровые; 2 группа - с признаками диареи; 3 группа - с признаками диареи, подвергались лечению. Исследуемую композицию задавали внутрь в течение 14 суток в суточной дозе 700 мл/гол. На протяжении всего эксперимента учитывали клиническое состояние животных, в начале опыта и через 14 суток у животных отбирали пробы кала для определения состава микробиома пищеварительного тракта. Результаты исследований показали, что состав микробиома телят, имеющих признаки диареи, существенно отличался от такового здоровых животных: отмечали смещение баланса в сторону условно-патогенных видов, снижение количества кишечной палочки. Применение исследуемого препарата для лечения телят с признаками диареи приводило к нормализации микробного пейзажа пищеварительного тракта. Положительный эффект подтверждался клинической...
- 1 January 2023
- Published by Federal Center for Toxicological, Radiation and Biological Safety in The Veterinarian
- No. 2,p. 28-32
Open AccessEvaluation of the effectiveness of the experimental composition as a therapeutic agent for diarrhea of young cattle
У телят молочного периода выращивания часто встречаются расстройства работы органов пищеварения, сопровождающиеся нарушением состава микрофлоры пищеварительного тракта со сдвигом соотношения в сторону условно-патогенных видов, что приводит к диарее, снижает продуктивность животных. В связи с этим не теряет актуальности вопрос разработки новых средств борьбы с расстройствами пищеварения продуктивного скота. Исследования проведены в трех хозяйствах Республики Мордовия, в экспериментах оценивали эффективность нового препарата (композиции, полученной на основе селимакцида и мицелиального гриба Fusarium sambucinum штамма ВКПМ F-139) как лечебного средства при диарее молодняка крупного рогатого скота. Из опытных животных - телят молочного периода выращивания - в каждом из трех опытов составляли 3 группы по 10 голов: 1 группа - здоровые; 2 группа - с признаками диареи; 3 группа - с признаками диареи, подвергались лечению. Исследуемую композицию задавали внутрь в течение 14 суток в суточной дозе 700 мл/гол. На протяжении всего эксперимента учитывали клиническое состояние животных, в начале опыта и через 14 суток у животных отбирали пробы кала для определения состава микробиома пищеварительного тракта. Результаты исследований показали, что состав микробиома телят, имеющих признаки диареи, существенно отличался от такового здоровых животных: отмечали смещение баланса в сторону условно-патогенных видов, снижение количества кишечной палочки. Применение исследуемого препарата для лечения телят с признаками диареи приводило к нормализации микробного пейзажа пищеварительного тракта. Положительный эффект подтверждался клинической...
- 1 September 2020
- Published by Springer Nature in BioNanoScience
- Vol. 10 (3) , 799-806
Comparative Toxicity Assessment of Soil Fungi Isolated from Black Sea Coasts
- 1 September 2020
- Published by Springer Nature in BioNanoScience
- Vol. 10 (3) , 799-806
Comparative Toxicity Assessment of Soil Fungi Isolated from Black Sea Coasts